Clinical trials: Exploring the limits of transparency
European Public Health Alliance
Glenis Willmott MEP (S&D, UK) took the initiative to bring together experts in order to discuss the extent to which more transparency is perceived to be workable in non-commercial clinical trials. The debate, which took place in the European Parliament